On March 26, 2014, FDA is conducting a public meeting on Patient-Focused Drug Development for#fibromyalgia.

FDA is interested in obtaining patient input on the impact of fibromyalgia on daily life and patients’ views on currently available therapies to treat the condition.

This is a rescheduling of the original December 10, 2013 meeting.

913

This website will be updated as additional meeting information becomes available. http://www.fda.gov/forindustry/userfees/prescriptiondruguserfee/ucm363203.htm

Date: March 26, 2014
Time: 1:00 p.m. to 5:00 p.m.
Location: FDA White Oak Campus
10903 New Hampshire Ave.
Building 31, Room 1503 B and C (Great Room)
Silver Spring, MD 20993
(Information about arrival to FDA’s White Oak campus)

Registration:
To register for this meeting, visit: https://marchfibromyalgia.eventbrite.com/.

Registration will close on March 20, 2014.

Source:  www.fda.gov

2014 The NW Fire Blog